[Viral failure in infants perinatally infected with HIV: A double punishment]

Arch Pediatr. 2017 Apr;24(4):317-326. doi: 10.1016/j.arcped.2017.01.006. Epub 2017 Feb 24.
[Article in French]

Abstract

Background: Considering the remarkable efficacy of the strategies for preventing mother-to-child transmission of HIV infection (PMTCT), failures are rare in high-resource countries and deserve further investigation. Moreover, infants have been found to be at increased risk of viral failure. We analyzed the factors related to the children's environment, including maternal psychological factors that may be associated with viral failure in children diagnosed before the age of 1 year.

Patients and methods: Retrospective study of all HIV-infected infants, born in France between July 2003 and July 2013, diagnosed before the age of 1 year, cared for in a single reference center, comparing the group of children in viral success to the group of children presenting at least one episode of viral failure, using data available in their medical, psychological and social files.

Results: Out of 1061 infants included in the prospective PMTCT follow-up, eight infants were found HIV-positive and an additional six cases were referred from other centers before the age of 1 year, for a total of 14 children born to 13 mothers. Seven children presented durable optimal viral control (VL<50 c/mL) whereas seven others did not reach or maintain optimal viral control over time. The main difference between the two groups was the presence among the mothers of children with viral failure of severe psychological disorders, leading to treatment adherence problems in the mothers who were aware of their HIV status before pregnancy, and difficulties in giving their children's treatments correctly.

Conclusions: Although seroconversion during pregnancy is responsible for a significant proportion of residual transmission in high-resource countries, severe psychological or psychiatric conditions in HIV-positive mothers play an important role on the risk of both MTC residual transmission and viral failure in their infants.

MeSH terms

  • Anti-HIV Agents / therapeutic use*
  • Female
  • Follow-Up Studies
  • HIV Infections / prevention & control*
  • HIV Infections / psychology
  • HIV Infections / transmission*
  • HIV-1 / drug effects
  • Humans
  • Infant
  • Infant, Newborn
  • Infectious Disease Transmission, Vertical / prevention & control*
  • Male
  • Medication Adherence / psychology
  • Mothers / psychology
  • Pregnancy
  • Retrospective Studies
  • Risk Factors
  • Treatment Failure

Substances

  • Anti-HIV Agents